Your email has been successfully added to our mailing list.

×
0 0 0.0344827586206897 0.0344827586206897 0.0344827586206897 0.0344827586206897 0.0344827586206897 0.0344827586206897
Stock impact report

Galena Q1 net loss $11.7M; two legal issues resolved; shares off 6% after hours [Seeking Alpha]

GALENA BIOPHARMA (GALE) 
Company Research Source: Seeking Alpha
Galena Biopharma's (NASDAQ: GALE ) net loss for Q1 narrowed to ($11.7M) from ($16.5M) while its unrestricted cash balance improved 52% to $27.6M. CEO Stephen Ghiglieri says the company has reached agreements with the SEC, U.S. Attorney's Office for the District of New Jersey and the U.S. Department of Justice to settle investigations into its Abstral (fentanyl) promotional practices. The company's previously announced review of strategic alternatives, including an outright sale or merger, is ongoing. Shares are down   after hours on light volume. Previously: Galena subject in criminal investigation into Abstral promotional practices; shares off 18% premarket (Jan. 9) Now read: KemPharm 2017 Q1 - Results - Earnings Call Slides » Show less Read more
Impact Snapshot
Event Time:
GALE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GALE alerts
Opt-in for
GALE alerts

from News Quantified
Opt-in for
GALE alerts

from News Quantified